These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 2488563

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Controlled trial of the prolactin inhibitor bromocriptine (Parlodel) in the treatment of severe cyclical mastalgia.
    Nazli K, Syed S, Mahmood MR, Ansari F.
    Br J Clin Pract; 1989 Sep; 43(9):322-7. PubMed ID: 2695151
    [Abstract] [Full Text] [Related]

  • 3. Histologic changes in fibrocystic breast disease before and after treatment with bromocriptine.
    Murta EF, de Freitas MM, Velludo MA.
    Rev Paul Med; 1992 Sep; 110(6):251-6. PubMed ID: 1341021
    [Abstract] [Full Text] [Related]

  • 4. Fibrocystic breast disease.
    Scott EB.
    Am Fam Physician; 1987 Oct; 36(4):119-26. PubMed ID: 3314435
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Mechanisms and effects of bromocriptine in the treatment of breast hyperplasia].
    Gao SQ.
    Zhonghua Wai Ke Za Zhi; 1988 Dec; 26(12):733-5, 781-2. PubMed ID: 3248468
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A double blind trial of the prolactin inhibitor bromocriptine in painful benign breast disease.
    Mansel RE, Preece PE, Hughes LE.
    Br J Surg; 1978 Oct; 65(10):724-7. PubMed ID: 361149
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serum prolactin and oestradiol levels in women with cyclical mastalgia.
    Watt-Boolsen S, Andersen AN, Blichert-Toft M.
    Horm Metab Res; 1981 Dec; 13(12):700-2. PubMed ID: 7319468
    [Abstract] [Full Text] [Related]

  • 15. A randomised controlled trial of medroxyprogesterone acetate in mastalgia.
    Maddox PR, Harrison BJ, Horobin JM, Walker K, Mansel RE, Preece PE, Nicholson RI.
    Ann R Coll Surg Engl; 1990 Mar; 72(2):71-6. PubMed ID: 2139769
    [Abstract] [Full Text] [Related]

  • 16. Mastalgia.
    Preece PE.
    Practitioner; 1982 Aug; 226(1370):1373-82. PubMed ID: 7134151
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A double-blind controlled trial of danazol and bromocriptine in the management of severe cyclical breast pain.
    Hinton CP, Bishop HM, Holliday HW, Doyle PJ, Blamey RW.
    Br J Clin Pract; 1986 Aug; 40(8):326-30. PubMed ID: 3527249
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of benign fibrocystic disease of the breast with 2-bromo-alpha-ergocryptine (CB 154).
    Santoro C, Cappa M, Moretti C, Fabbri A, La Vecchia V, Romano Marcellino L, Fraioli F.
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):479-81. PubMed ID: 6815107
    [Abstract] [Full Text] [Related]

  • 20. [Fibrocystic disease of breast. Clinico-therapeutic considerations].
    Favia G, Lumachi F, D'Amico C, De Battisti S, Annunziata N, Berto M.
    Minerva Chir; 1988 May 15; 43(9):759-62. PubMed ID: 3173746
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.